Literature DB >> 23816970

Assessment of tocilizumab in the treatment of cancer cachexia.

Alvise Berti, Francesco Boccalatte, Maria Grazia Sabbadini, Lorenzo Dagna.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23816970     DOI: 10.1200/JCO.2012.48.4147

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  10 in total

Review 1.  Immunotherapy for ovarian cancer.

Authors:  Justin M Drerup; Yang Liu; Alvaro S Padron; Kruthi Murthy; Vincent Hurez; Bin Zhang; Tyler J Curiel
Journal:  Curr Treat Options Oncol       Date:  2015-01

Review 2.  Role of interleukin-6 in cachexia: therapeutic implications.

Authors:  Aditi A Narsale; James A Carson
Journal:  Curr Opin Support Palliat Care       Date:  2014-12       Impact factor: 2.302

Review 3.  Taming the Flames: Targeting White Adipose Tissue Browning in Hypermetabolic Conditions.

Authors:  Abdikarim Abdullahi; Marc G Jeschke
Journal:  Endocr Rev       Date:  2017-12-01       Impact factor: 19.871

Review 4.  Metabolic Reprogramming in Adipose Tissue During Cancer Cachexia.

Authors:  Bahar Zehra Camurdanoglu Weber; Dilsad H Arabaci; Serkan Kir
Journal:  Front Oncol       Date:  2022-05-12       Impact factor: 5.738

5.  Cancer-associated fibroblasts promote endometrial cancer growth via activation of interleukin-6/STAT-3/c-Myc pathway.

Authors:  Kavita S Subramaniam; Intan Sofia Omar; Soke Chee Kwong; Zahurin Mohamed; Yin Ling Woo; Noor Azmi Mat Adenan; Ivy Chung
Journal:  Am J Cancer Res       Date:  2016-01-15       Impact factor: 6.166

6.  Rapid decline in visceral adipose tissue over 1 month is associated with poor prognosis in patients with unresectable pancreatic cancer.

Authors:  Oki Nakano; Hirokazu Kawai; Takamasa Kobayashi; Junji Kohisa; Satoshi Ikarashi; Kazunao Hayashi; Junji Yokoyama; Shuji Terai
Journal:  Cancer Med       Date:  2021-05-16       Impact factor: 4.452

7.  Changes in body composition and metabolic profile during interleukin 6 inhibition in rheumatoid arthritis.

Authors:  Anne Tournadre; Bruno Pereira; Fréderic Dutheil; Charlotte Giraud; Daniel Courteix; Vincent Sapin; Thomas Frayssac; Sylvain Mathieu; Sandrine Malochet-Guinamand; Martin Soubrier
Journal:  J Cachexia Sarcopenia Muscle       Date:  2017-03-18       Impact factor: 12.910

8.  Establishment and characterization of a novel murine model of pancreatic cancer cachexia.

Authors:  Katherine A Michaelis; Xinxia Zhu; Kevin G Burfeind; Stephanie M Krasnow; Peter R Levasseur; Terry K Morgan; Daniel L Marks
Journal:  J Cachexia Sarcopenia Muscle       Date:  2017-07-20       Impact factor: 12.910

Review 9.  Myokines as Possible Therapeutic Targets in Cancer Cachexia.

Authors:  Emilia Manole; Laura C Ceafalan; Bogdan O Popescu; Carmen Dumitru; Alexandra E Bastian
Journal:  J Immunol Res       Date:  2018-10-22       Impact factor: 4.818

10.  Determination of the Monoclonal Antibody Tocilizumab by a Validated Micellar Electrokinetic Chromatography Method.

Authors:  Sahar Zayed; Fathalla Belal
Journal:  Chromatographia       Date:  2022-04-01       Impact factor: 2.213

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.